Fig. 5: Nomogram for individualized risk assessment in MDS. | Blood Cancer Journal

Fig. 5: Nomogram for individualized risk assessment in MDS.

From: Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification

Fig. 5: Nomogram for individualized risk assessment in MDS.

A clinical-genomic prognostic nomogram developed using a multivariable Cox-based model incorporating age, ferritin level (800 ng/mL), LDH level (200 U/L), bone marrow fibrosis, and refined IPSS-M categories. The model allows for the individualized estimation of 12- and 36-month survival probabilities.

Back to article page